BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2008

Conditions

Breast CancerEndometrial CancerHead and Neck CancerMelanoma (Skin)Ovarian CancerSarcoma

Interventions

DRUG

BI 2536

OTHER

high performance liquid chromatography

OTHER

mass spectrometry

OTHER

pharmacological study

Trial Locations (1)

U.Z. Gasthuisberg, Leuven

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00526149 - BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter